Tags

Type your tag names separated by a space and hit enter

Dietary Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAPs) and Gastrointestinal Disease.
Nutr Clin Pract 2018; 33(4):468-475NC

Abstract

FODMAP is an acronym for fermentable oligosaccharides, disaccharides, monosaccharides, and polyols. Dietary modification of FODMAPs has been shown to have significant effects on the physiology of the gastrointestinal tract and improves symptoms of abdominal pain, distention, and bloating in patients with irritable bowel syndrome. Structured withdrawal and reintroduction of FODMAPs supervised by a dietitian is the optimal practice for dietary FODMAP modification in irritable bowel syndrome. FODMAPs are present in enteral feeding formulas and may have a role in diarrhea and bloating in tube-fed patients. Emerging areas of research include the effects of dietary modification of FODMAPs on the microbiome, micronutrient absorption, and caloric intake. FODMAP dietary modification is an emerging area in other gastrointestinal disorders and is of relevance to all practicing dietitians.

Authors+Show Affiliations

University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. Aurora Health Care, Summit, Wisconsin, USA.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

29870082

Citation

Vakil, Nimish. "Dietary Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAPs) and Gastrointestinal Disease." Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition, vol. 33, no. 4, 2018, pp. 468-475.
Vakil N. Dietary Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAPs) and Gastrointestinal Disease. Nutr Clin Pract. 2018;33(4):468-475.
Vakil, N. (2018). Dietary Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAPs) and Gastrointestinal Disease. Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition, 33(4), pp. 468-475. doi:10.1002/ncp.10108.
Vakil N. Dietary Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAPs) and Gastrointestinal Disease. Nutr Clin Pract. 2018;33(4):468-475. PubMed PMID: 29870082.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Dietary Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAPs) and Gastrointestinal Disease. A1 - Vakil,Nimish, Y1 - 2018/06/05/ PY - 2018/6/6/pubmed PY - 2018/11/16/medline PY - 2018/6/6/entrez KW - FODMAP KW - disaccharides KW - enteral nutrition KW - inflammatory bowel diseases KW - irritable bowel syndrome KW - microbiota KW - monosacccharides KW - oligosaccharides KW - polysaccharides KW - sugar alcohols SP - 468 EP - 475 JF - Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition JO - Nutr Clin Pract VL - 33 IS - 4 N2 - FODMAP is an acronym for fermentable oligosaccharides, disaccharides, monosaccharides, and polyols. Dietary modification of FODMAPs has been shown to have significant effects on the physiology of the gastrointestinal tract and improves symptoms of abdominal pain, distention, and bloating in patients with irritable bowel syndrome. Structured withdrawal and reintroduction of FODMAPs supervised by a dietitian is the optimal practice for dietary FODMAP modification in irritable bowel syndrome. FODMAPs are present in enteral feeding formulas and may have a role in diarrhea and bloating in tube-fed patients. Emerging areas of research include the effects of dietary modification of FODMAPs on the microbiome, micronutrient absorption, and caloric intake. FODMAP dietary modification is an emerging area in other gastrointestinal disorders and is of relevance to all practicing dietitians. SN - 1941-2452 UR - https://www.unboundmedicine.com/medline/citation/29870082/Dietary_Fermentable_Oligosaccharides_Disaccharides_Monosaccharides_and_Polyols__FODMAPs__and_Gastrointestinal_Disease_ L2 - https://doi.org/10.1002/ncp.10108 DB - PRIME DP - Unbound Medicine ER -